Abstract
Breast cancer screening programs have been effective in detecting tumors prior to symptoms. Recently, there has been concern over the issue of over-diagnosis, that is, diagnosis of a breast cancer that does not manifest prior to death. Estimates for over-diagnosis vary, ranging from 7 to 52%. This variability may be due partially to issues associated with bias and/or incorrect inferences associated with the lack of probability modeling. A critical issue is how to evaluate the long-term effects due to continued screening. Participants in a periodic screening program can be classified into four mutually exclusive groups depending on whether individuals are diagnosed and whether their symptoms appear prior to death: True-early-detection; No-early-detection; Over-diagnosis; and Not-so-necessary. All initially superficially healthy people will eventually fall into one of these four categories. This manuscript reviews the major methodologies associated with the over-diagnosis and long-term effects of breast cancer screening.
Similar content being viewed by others
References
Day NE (2005) Overdiagnosis and breast cancer screening. Breast Cancer Res 7:228–229
Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP (2006) Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. BMJ 332:689–692
Jørgensen KJ, Gøtzsche PC (2009) Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. British Med J, doi:10.1136/bmj.b2587
Badgwell BD, Giordano SH, Duan ZZ et al (2008) Mammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol 26:2482–2488
Duffy SW, Lynge E, Jonsson H et al (2008) Complexities in the estimation of overdiagnosis in breast cancer screening. Br J Cancer 99:1176–1178
Gøtzsche PC, Jørgensen KJ, Mahlen J, Zahl PH (2009) Estimation of lead time and overdiagnosis in breast cancer screening. Br J Cancer 100:219
Zahl PH, Mahlen J, Welch HG (2008) The natural history of invasive breast cancers detected by screening mammography. Arch intern Med 168:2311–2316
Paci E, Duffy SW (2005) Overdiagnosis and overtreatment of breast cancer: overdiagnosis and overtreatment in service screening. Breast Cancer Res 7:266–270
Davidov O, Zelen M (2004) Overdiagnosis in early detection programs. Biostatistics 5:603–613
Wu D, Rosner GL (2010) A projection of true-early-detection, no-early-detection, over-diagnosis and not-so-necessary probabilities in tumor screening. In: Proceedings of the American Statistical Association, Biopharmaceutical Section. American Statistical Association, Alexandria, 1144–1157
Shapiro S, Venet W, Strax P, Venet L (1988) Periodic Screening for Breast Cancer: The Health Insurance Plan Project and its Sequelae, 1963–1986. The Johns Hopkins University Press, Baltimore
Wu D, Rosner GL, Broemeling LD (2005) MLE and Bayesian inference of age-dependent sensitivity and transition probability in periodic screening. Biometrics 61:1056–1063
Social Security Administration (2010) Period Life Table. Actuarial Publications. http://www.ssa.gov/OACT/STATS/table4c6.html Accessed 01 August 2010
Acknowledgments
The authors thank Dr. Kathy Baumgartner for her valuable comments and suggestions. We thank the anonymous reviewers for their valuable suggestions and comments for improving this paper. The second author was supported by a research supplement (3R37CA057030-20S1) from the National Cancer Institute during the writing of this manuscript.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wu, D., Pérez, A. A limited review of over diagnosis methods and long-term effects in breast cancer screening. Oncol Rev 5, 143–147 (2011). https://doi.org/10.1007/s12156-011-0077-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12156-011-0077-0